Investigating KRAS/BRAF mutation in oropharyngeal squamous cell carcinomas: a preliminary study

Volume: 26 Number: 5 October 20, 2016
  • Ülkü Küçük
  • Ümit Bayol
  • Elif Usturalı Keskin
  • Emel Ebru Pala
  • İbrahim Çukurova
  • Mehmet Ali Çolak
  • Mustafa Değirmenci
  • Özge Özer
  • Altuğ Koç
TR EN

Investigating KRAS/BRAF mutation in oropharyngeal squamous cell carcinomas: a preliminary study

Abstract

Objectives: This study aims to investigate the role of KRAS/BRAF gene mutation in the pathogenesis of oropharyngeal squamous cell carcinoma OSCC . Patients and Methods: A total of 26 OSCC patients 23 males, 3 females; mean age 60 years; range 41 to 77 years diagnosed between January 2003 and November 2013 were included in the study. The methods used in our study were quantitative fluorescence polymerase chain reaction for KRAS/BRAF mutation analysis. Results: Ten of the tumors were located at the tongue base, 12 in the tonsil and four at the floor of mouth. The mean tumor size was 3.8 cm. Six of the tumors were well differentiated, 18 were moderately differentiated and two were poorly differentiated. All cases were analyzed for KRAS and BRAF gene mutations and none of them showed gene mutations. Conclusion: We could not find any relation between OSCC and KRAS/BRAF gene mutations in our short case file. The role of mutations should be analyzed in larger series in OSCC to predict new targeted therapy modalities.

Keywords

References

  1. Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004;31:744-54.
  2. Bissada E, Abboud O, Abou Chacra Z, Guertin L, Weng X, Nguyen-Tan PF, et al. Prevalence of K-RAS Codons 12 and 13 Mutations in Locally Advanced Head and Neck Squamous Cell Carcinoma and Impact on Clinical Outcomes. Int J Otolaryngol 2013;2013:848021.
  3. Spencer JM, Kahn SM, Jiang W, DeLeo VA, Weinstein IB. Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. Arch Dermatol 1995;131:796-800.
  4. McDonald JS, Jones H, Pavelic ZP, Pavelic LJ, Stambrook PJ, Gluckman JL. Immunohistochemical detection of the H-ras, K-ras, and N-ras oncogenes in squamous cell carcinoma of the head and neck. J Oral Pathol Med 1994;23:342-6.
  5. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949-54.
  6. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005;114:806-16.
  7. De Carvalho TG, De Carvalho AC, Maia DC, Ogawa JK, Carvalho AL, Vettore AL. Search for mutations in signaling pathways in head and neck squamous cell carcinoma. Oncol Rep 2013;30:334-40.
  8. Langer CJ. Exploring biomarkers in head and neck cancer. Cancer 2012;118:3882-92.

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Ülkü Küçük This is me

Ümit Bayol This is me

Elif Usturalı Keskin This is me

Emel Ebru Pala This is me

İbrahim Çukurova This is me

Mehmet Ali Çolak This is me

Mustafa Değirmenci This is me

Özge Özer This is me

Altuğ Koç This is me

Publication Date

October 20, 2016

Submission Date

-

Acceptance Date

-

Published in Issue

Year 2016 Volume: 26 Number: 5

APA
Küçük, Ü., Bayol, Ü., Usturalı Keskin, E., Pala, E. E., Çukurova, İ., Çolak, M. A., Değirmenci, M., Özer, Ö., & Koç, A. (2016). Investigating KRAS/BRAF mutation in oropharyngeal squamous cell carcinomas: a preliminary study. The Turkish Journal of Ear Nose and Throat, 26(5), 265-267. https://izlik.org/JA88KY36DR
AMA
1.Küçük Ü, Bayol Ü, Usturalı Keskin E, et al. Investigating KRAS/BRAF mutation in oropharyngeal squamous cell carcinomas: a preliminary study. Tr-ENT. 2016;26(5):265-267. https://izlik.org/JA88KY36DR
Chicago
Küçük, Ülkü, Ümit Bayol, Elif Usturalı Keskin, et al. 2016. “Investigating KRAS BRAF Mutation in Oropharyngeal Squamous Cell Carcinomas: A Preliminary Study”. The Turkish Journal of Ear Nose and Throat 26 (5): 265-67. https://izlik.org/JA88KY36DR.
EndNote
Küçük Ü, Bayol Ü, Usturalı Keskin E, Pala EE, Çukurova İ, Çolak MA, Değirmenci M, Özer Ö, Koç A (October 20, 2016) Investigating KRAS/BRAF mutation in oropharyngeal squamous cell carcinomas: a preliminary study. The Turkish Journal of Ear Nose and Throat 26 5 265–267.
IEEE
[1]Ü. Küçük et al., “Investigating KRAS/BRAF mutation in oropharyngeal squamous cell carcinomas: a preliminary study”, Tr-ENT, vol. 26, no. 5, pp. 265–267, Oct. 2016, [Online]. Available: https://izlik.org/JA88KY36DR
ISNAD
Küçük, Ülkü - Bayol, Ümit - Usturalı Keskin, Elif - Pala, Emel Ebru - Çukurova, İbrahim - Çolak, Mehmet Ali - Değirmenci, Mustafa - Özer, Özge - Koç, Altuğ. “Investigating KRAS BRAF Mutation in Oropharyngeal Squamous Cell Carcinomas: A Preliminary Study”. The Turkish Journal of Ear Nose and Throat 26/5 (October 20, 2016): 265-267. https://izlik.org/JA88KY36DR.
JAMA
1.Küçük Ü, Bayol Ü, Usturalı Keskin E, Pala EE, Çukurova İ, Çolak MA, Değirmenci M, Özer Ö, Koç A. Investigating KRAS/BRAF mutation in oropharyngeal squamous cell carcinomas: a preliminary study. Tr-ENT. 2016;26:265–267.
MLA
Küçük, Ülkü, et al. “Investigating KRAS BRAF Mutation in Oropharyngeal Squamous Cell Carcinomas: A Preliminary Study”. The Turkish Journal of Ear Nose and Throat, vol. 26, no. 5, Oct. 2016, pp. 265-7, https://izlik.org/JA88KY36DR.
Vancouver
1.Ülkü Küçük, Ümit Bayol, Elif Usturalı Keskin, Emel Ebru Pala, İbrahim Çukurova, Mehmet Ali Çolak, Mustafa Değirmenci, Özge Özer, Altuğ Koç. Investigating KRAS/BRAF mutation in oropharyngeal squamous cell carcinomas: a preliminary study. Tr-ENT [Internet]. 2016 Oct. 20;26(5):265-7. Available from: https://izlik.org/JA88KY36DR